background
herp
simplex
viru
resist
drug
side
effect
drug
drawn
attent
investig
herbal
plant
object
main
aim
current
research
investig
effect
glycyrrhiza
glabra
liquoric
root
one
object
current
research
determin
efficaci
effect
elaps
incub
time
treat
vero
cell
infect
g
glabra
addit
effect
cell
pretreat
licoric
root
extract
preincub
viru
licoric
root
extract
antivir
activ
assess
patient
method
vero
cell
incub
ad
differ
concentr
aqueou
extract
g
glabra
cell
incub
variou
time
cours
cytotox
assay
determin
tissu
cultur
infecti
dose
tcid
incub
licoric
root
extract
prior
viral
infect
perform
result
intern
associ
among
differ
experi
group
show
signific
differ
efficaci
extract
regard
incub
period
one
four
hour
one
eight
hour
four
hour
eight
hour
moreov
signific
differ
regard
efficaci
among
pretreat
cell
extract
two
hour
incub
viru
extract
one
hour
incub
viru
extract
two
hour
conclus
g
glabra
show
characterist
novel
antivir
medic
howev
vitro
experi
need
determin
antiherpet
activ
g
glabra
herp
simplex
viru
resist
drug
side
effect
due
drug
consumpt
drawn
attent
investig
find
new
medicin
herbal
plant
glycyrrhiza
glabra
may
novel
choic
antivir
treatment
herp
simplex
viru
member
herpesvirida
caus
sever
diseas
neonat
elderli
patient
druginduc
immunosuppress
acquir
immunodefici
syndrom
aid
nowaday
increas
resist
antiherpet
drug
report
frequent
due
drug
side
effect
hsv
resist
antivir
drug
especi
resist
acyclovir
highrisk
immunocompromis
patient
new
medic
includ
herbal
plant
glycyrrhiza
glabra
licoric
root
drawn
especi
interest
highlight
need
new
effici
safe
agent
treat
hsv
manuscript
china
greec
india
confirm
histor
background
glycyrrhiza
speci
use
china
licoric
gan
cao
report
one
oldest
commonli
prescrib
tradit
medicin
use
treatment
sever
diseas
g
glabra
natur
habitat
southwest
central
asia
well
subtrop
temper
area
planet
includ
europ
root
term
licoric
sweet
odor
smell
genu
glycyrrhiza
leguminosa
includ
speci
g
glabra
g
uralensi
g
inflata
g
aspera
persian
turkish
licoric
determin
g
glabra
var
violac
first
report
indic
antivir
properti
licoric
constitu
date
back
research
scientist
recogn
glycyrrhiz
acid
antivir
activ
vitro
suppress
growth
cytopath
effect
cpe
numer
dna
rna
virus
newcastl
diseas
vaccinia
viru
vesicular
stomat
viru
report
indic
minor
constitu
g
glabra
liquiritigenin
isoliquiritigenin
might
pharmacolog
function
acyclovir
nucleosid
analog
antiherpet
drug
partial
fulfil
need
treat
infect
entir
howev
lead
viral
resist
consequ
viral
latenc
recurr
regard
increas
rate
hsv
resist
drug
evid
infect
major
women
fertil
age
iran
find
novel
antihsv
drug
seem
necessari
main
goal
current
studi
vitro
evalu
possibl
antiherpet
virucid
activ
g
glabra
possibl
viru
inhibit
yield
effect
licoric
extract
determin
tissu
cultur
infecti
dose
tcid
per
millilit
vero
cell
one
object
current
research
determin
efficaci
respect
elaps
incub
time
treatment
cell
infect
hsv
licoric
extract
assess
antivir
activ
g
glabra
viru
adsorpt
addit
effect
pretreat
cell
licoric
root
extract
preincub
viru
g
glabra
object
current
studi
licoric
root
prepar
kermanshah
western
provinc
iran
shown
licoric
root
best
qualiti
iran
licoric
root
dri
grin
powder
powder
use
extract
four
gram
dri
powder
suspend
ml
steril
distil
water
kept
hour
incub
eight
hour
room
temperatur
mix
magnet
mixer
next
step
suspens
kept
hour
room
temperatur
final
mixtur
pass
filter
preserv
time
use
vero
cell
african
green
monkey
kidney
cell
provid
depart
virolog
faculti
public
health
tehran
univers
medic
scienc
tehran
iran
vero
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
addit
antibiot
name
penicillin
streptomycin
vero
cell
incub
co
herp
simplex
viru
obtain
pasteur
institut
tehran
iran
cytopathogen
dose
assess
express
tcid
ml
order
determin
appropri
concentr
aqueou
extract
licoric
root
less
cytotox
vero
cell
neutral
red
assay
employ
microtitr
plate
contain
tissu
cultur
plate
inocul
vero
cell
achiev
confluenc
cell
wash
prewarm
phosphat
buffer
salin
pb
differ
concentr
licoric
root
extract
prepar
dmem
ad
assign
well
plate
incub
co
two
day
two
day
vero
cell
wash
prewarm
pb
filter
neutral
red
solut
ad
well
viabl
cell
absorb
neutral
red
dye
plate
incub
co
incub
three
hour
incub
cell
wash
prewarm
pb
neutral
red
dye
stain
solut
ad
well
plate
shaken
dark
shaker
ten
minut
neutral
red
dye
remov
optic
densiti
neutral
red
solut
measur
nm
elisa
reader
sunris
remot
tecan
austria
tabl
highest
concentr
less
cytotox
vero
cell
mgml
use
experi
figur
vero
cell
cultur
micropl
inocul
serial
dilut
micropl
incub
one
hour
co
incub
incub
period
well
wash
pb
dmem
medium
ad
well
micropl
incub
co
seven
day
examin
daili
presenc
cpe
experi
examin
three
time
titer
prepar
determin
reed
muench
method
antivir
effect
licoric
root
extract
design
evalu
three
step
discuss
determin
whether
extract
antiherpet
activ
viru
particl
viru
serial
dilut
prepar
noncytotox
concentr
mg
ml
licoric
root
extract
incub
one
hour
incub
viru
dilut
use
infect
vero
cell
incub
co
incub
one
hour
follow
one
hour
incub
unabsorb
viru
prepar
remov
cell
wash
pb
dmem
fb
ad
monolay
cell
micropl
incub
co
examin
seven
day
evid
cpe
vero
cell
pretreat
nontox
concentr
extract
mgml
two
hour
co
next
step
extract
remov
cell
wash
pb
inocul
tcid
ml
step
describ
micropl
monitor
seven
day
detect
cpe
infect
monolay
cell
tcid
ml
one
hour
incub
vero
cell
wash
pb
nontox
concentr
extract
mgml
dmem
ad
monolay
cell
one
four
eight
twelv
hour
viral
infect
plate
incub
co
incub
monitor
daili
seven
day
viral
titer
determin
endpoint
dilut
method
calcul
tcid
compar
control
viru
sampl
prepar
obtain
data
analyz
use
spss
spss
inc
chicago
il
usa
oneway
anova
test
use
compar
quantit
paramet
among
studi
group
case
differ
among
group
tukey
hsd
test
util
determin
differ
group
test
consid
statist
signific
p
valu
less
cytotox
licoric
root
extract
examin
neutral
red
assay
mean
valu
well
assign
extract
concentr
measur
highest
dilut
less
cytotox
vero
cell
equal
concentr
mg
ml
mention
concentr
vero
cell
appear
normal
notic
cpe
seen
microscop
monitor
therefor
concentr
higher
mgml
use
experi
possibl
inhibit
viru
yield
effect
licoric
extract
assess
tcid
ml
vero
cell
comparison
viru
stock
tcid
ml
describ
previous
examin
possibl
inhibitori
effect
licoric
root
extract
yield
three
step
tcid
viru
two
experi
reduc
one
logarithm
comparison
control
viru
signific
order
assess
antiherpet
activ
licoric
root
extract
viru
adsorpt
licoric
extract
incub
vero
cell
infect
hsv
one
four
eight
twelv
hour
postinfect
result
show
effect
extract
chang
regard
elaps
time
incub
f
df
p
tukey
hsd
test
show
similar
effect
elaps
time
four
eight
hour
incub
extract
comparison
control
viru
signific
p
p
respect
howev
effect
extract
signific
one
hour
incub
extract
comparison
control
viru
logarithm
variat
p
tabl
compar
intern
associ
among
differ
group
experi
show
differ
efficaci
extract
respect
elaps
incub
time
signific
one
four
hour
one
eight
hour
four
hour
eight
hour
chang
log
tabl
figur
compar
effect
pretreat
cell
licoric
root
extract
preincub
viru
infect
monolay
cell
onehour
incub
period
nontox
concentr
extract
dmem
ad
monolay
cell
one
four
eight
twelv
hour
viral
infect
plate
incub
co
incub
monitor
daili
seven
day
viral
titer
determin
endpoint
dilut
method
calcul
tissu
cellular
infecti
dose
compar
control
viru
sampl
prepar
vero
cell
pretreat
nontox
concentr
extract
two
hour
co
next
step
cell
infect
onehour
twohour
incub
period
vero
cell
wash
pb
nontox
concentr
extract
dmem
ad
monolay
cell
micropl
monitor
seven
day
presenc
cytopath
effect
calcul
tissu
cellular
infecti
dose
tcid
compar
control
viru
sampl
prepar
licoric
root
extract
new
experi
design
ie
result
compar
control
viru
pretreat
cell
extract
two
hour
incub
viru
extract
one
well
two
hour
signific
differ
among
studi
group
f
df
p
tukey
hsd
test
show
signific
effect
mention
group
comparison
control
viru
p
tabl
moreov
comparison
pretreat
cell
extract
two
hour
incub
viru
extract
one
hour
show
signific
differ
antivir
effect
licoric
root
extract
p
howev
effect
signific
comparison
incub
viru
extract
two
hour
p
incub
viru
licoric
root
extract
show
signific
differ
antivir
effect
licoric
root
extract
one
two
hour
incub
p
tabl
figur
result
current
studi
almost
uniqu
found
detail
concern
antiherpet
activ
licoric
root
extract
includ
key
observ
determin
efficaci
time
cours
extract
treatment
cell
infect
viru
thu
research
highlight
import
time
cours
process
antivir
effect
g
glabra
aqueou
extract
addit
role
viru
pretreat
licoric
root
extract
notabl
moreov
reliabl
tcid
test
determin
suitabl
concentr
licoric
root
aqueou
extract
mgml
less
cytotox
vero
cell
justifi
antiherpet
activ
licoric
root
extract
may
due
number
mechan
role
g
glabra
inhibit
hsv
attach
process
direct
contact
viru
extract
situat
inhibit
either
directli
inactiv
viru
antiadhes
properti
g
glabra
aqueou
extract
hamper
adhes
vero
cell
vitro
latter
hypothesi
agreement
wittschier
et
al
find
confirm
polysaccharid
isol
aqueou
extract
g
glabra
root
present
strong
antiadhes
properti
abl
suppress
adhes
helicobact
pylori
human
gastric
mucosa
wittschier
et
al
believ
effect
relat
polysaccharid
isol
aqueou
extract
g
glabra
furthermor
glycyrrhizin
glycyrrhiz
acid
capabl
hamper
growth
cpe
hsv
addit
base
result
current
studi
might
specul
suppress
replic
vero
cell
occur
interrupt
late
stage
gene
express
data
anoth
studi
appear
consist
interrupt
gene
express
hsv
medicin
plant
name
chamaecypari
obtus
howev
effect
immediateearli
stage
gene
express
moreov
tradit
chines
herb
name
tripterygium
hypoglaucum
shown
antihsv
properti
suppress
earli
late
stage
gene
express
studi
also
indic
licoric
root
constitu
perform
antivir
activ
hsv
perman
inactiv
viru
might
due
differ
compon
plant
includ
glycyrrhiz
acid
inactiv
hsv
particl
moreov
anim
studi
report
glycyrrhizin
deriv
capabl
decreas
viral
activ
mortal
rate
hsv
enceph
anoth
report
reveal
key
role
glycyrrhizin
improv
impair
resist
injur
mice
infect
hsv
compound
licoric
root
triterpen
glycosid
glycyrrhiz
acid
glycyrrhizin
aglycon
acid
confirm
antiinflammatori
antioxid
antitumor
antivir
properti
addit
antivir
effect
glycyrrhizin
suppress
replic
sever
virus
shown
vitro
glycyrrhizin
also
provid
plausibl
mechan
broad
spectrum
antivir
activ
includ
hsv
flaviviru
human
immunodefici
viru
vaccinia
viru
polioviru
type
vesicular
stomat
viru
iav
sarsrel
coronaviru
human
respiratori
syncyti
viru
arbovirus
futur
research
need
investig
effect
methanol
extract
g
glabra
compar
result
help
us
identifi
possibl
correl
differ
physiolog
effect
two
differ
extract
moreov
vivo
studi
conduct
identifi
signific
possibl
side
effect
cytotox
g
glabra
anim
model
high
risk
peopl
pregnant
women
elderli
heart
diseas
asthma
etc
help
us
verifi
inappropri
effect
g
glabra
applic
human
conclus
although
g
glabra
show
characterist
novel
antivir
medic
vitro
experi
need
declar
role
chemic
deriv
g
glabra
may
present
broad
rang
antiherpet
activ
